Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
Dexcom identified that specific lots of G7 sensors, which were designated as scrap and intended for destruction, were stolen. The company discovered the theft during routine quality and accounting reviews and has begun notifying potentially impacted users.
This alert affects users of the Dexcom G7 sensor, as well as regulatory, quality, and supply chain professionals at the manufacturer. The scope appears limited to the specific stolen lots.
The presence of stolen scrap product in the market poses significant safety risks, as these devices were previously earmarked for destruction due to non-conformance or other quality issues. This incident suggests a potential vulnerability in the product lifecycle management and disposal chain, necessitating a reconciliation between physical inventory and accounting records to detect unauthorized distribution.
Quality and accounting teams should review scrap disposal protocols and ensure chain of custody for products designated for destruction. Regulatory teams should monitor for unauthorized secondary market activity for these specific lots and ensure field safety notifications reach the intended users.
SAN DIEGO – MAY 26, 2026 – DexCom, Inc. (Nasdaq: DXCM), the global leader in glucose biosensing, announced today through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the
Open in openFDA / FDA.gov